Semaglutide

Signal Context

Pharma PR is selling a future of easy weight-loss fixes — call out manufacturers and outlets that conflate promising trial headlines with guaranteed access, and expose the real costs: supply bottlenecks, insurer denials, and out-of-pocket expenses for patients.